Breast cancer

Volpara, a Lunit Company, Secures U.S. Defense Health Agency Contract to Modernize Mammography Services

Volpara Health Surpasses 300 Peer-Reviewed Papers

Join us for a briefing for the Find It Early Act

New insights into high-risk MRI screening re-attendance

Turning the Tide on Breast Cancer Inequities in New Zealand: A Call to Action

Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care

AI to help your mammography MQSA audit…yes, really

Use International Women’s Day To Save Lives

Streamline technologist onboarding with the power of AI

In our breast cancer risk assessment era